Report Categories
View AllRecent Articles
View All
TBHC The Brand posts 424 percent negative EPS surprise in Q1 2026 as share price remains unchanged
HOTH Hoth Therapeutics reports wider than expected Q4 2025 quarterly loss even as its shares post a small daily gain
BLUW Blue Water 3 releases quarterly earnings update with management prioritizing sustainable marine sector SPAC merger targets
AbbVie Inc ABBV Former Senior Immunology RD Leader Anthony Slavin Appointed SVP of Portfolio Strategy at Infinimmune